ASPI | ASP Isotopes Inc. Common Stock Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	6.40 - 7.79
52 Week Range	1.0500 - 9.23
Beta	3.37
Implied Volatility	168.09%
IV Rank	-27.46%
Day's Volume	7,847,820
Average Volume	2,542,714
Shares Outstanding	66,686,940
Market Cap	434,798,849
Sector	Basic Materials
Industry	Chemicals
IPO Date	2022-11-10

Valuation
Profitability
Growth
Health
P/E Ratio	-10.52
Forward P/E Ratio	N/A
EPS	-0.62
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	76
Country	USA
Website	ASPI

ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.

ASPI's peers: GURE, ALTHF, AHKSY, AFPW, ASIX, AHKSF, SHECY, NNXPF

*Chart delayed

Analyzing fundamentals for ASPI we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is passable. For more detailed analysis please see ASPI Fundamentals page.

Watching at ASPI technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ASPI Technicals page.